Nizamudin, M., Kumar, M. P., Gautham, A., Sriram, D. K., & George, M. (2020). Roflumilast: First approved oral selective PDE4 inhibitor for the treatment of COPD. International Journal of Health and Clinical Research, 3(5), 85–89. Retrieved from https://ijhcr.com/index.php/ijhcr/article/view/157